Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
02 2021
Historique:
received: 18 07 2020
revised: 16 09 2020
accepted: 19 09 2020
pubmed: 26 9 2020
medline: 24 12 2021
entrez: 25 9 2020
Statut: ppublish

Résumé

The clinical presentation of cardiac sarcoidosis (CS) may resemble that of arrhythmogenic right ventricular cardiomyopathy (ARVC). The purpose of this study was to identify clinical variables to better discriminate between patients with genetically determined ARVC and those with CS fulfilling definite 2010 ARVC Task Force Criteria (TFC). In this multicenter study, 10 patients with CS fulfilling definite 2010 ARVC TFC were age and gender matched with 10 genetically proven ARVC patients. A cardiac The 2010 ARVC TFC did not reliably differentiate between the 2 diseases. CS patients presented with longer PR intervals, advanced atrioventricular block (AVB), and longer QRS duration (P <.001 and P = .009, respectively), whereas T-wave inversions (TWIs) in the peripheral leads were more common in ARVC patients (P = .009). CS patients presented with more extensive left ventricular involvement and lower left ventricular ejection fraction (LVEF), whereas ARVC patients had a larger right ventricular outflow tract (RVOT) (P = .044). PET scan positivity was only present in CS patients (90% vs 0%). The 2010 ARVC TFC do not reliably differentiate between CS patients fulfilling 2010 ARVC TFC and those with hereditary ARVC. Prolonged PR interval, advanced AVB, longer QRS duration, right ventricular apical involvement, reduced LVEF, and positive

Sections du résumé

BACKGROUND
The clinical presentation of cardiac sarcoidosis (CS) may resemble that of arrhythmogenic right ventricular cardiomyopathy (ARVC).
OBJECTIVE
The purpose of this study was to identify clinical variables to better discriminate between patients with genetically determined ARVC and those with CS fulfilling definite 2010 ARVC Task Force Criteria (TFC).
METHODS
In this multicenter study, 10 patients with CS fulfilling definite 2010 ARVC TFC were age and gender matched with 10 genetically proven ARVC patients. A cardiac
RESULTS
The 2010 ARVC TFC did not reliably differentiate between the 2 diseases. CS patients presented with longer PR intervals, advanced atrioventricular block (AVB), and longer QRS duration (P <.001 and P = .009, respectively), whereas T-wave inversions (TWIs) in the peripheral leads were more common in ARVC patients (P = .009). CS patients presented with more extensive left ventricular involvement and lower left ventricular ejection fraction (LVEF), whereas ARVC patients had a larger right ventricular outflow tract (RVOT) (P = .044). PET scan positivity was only present in CS patients (90% vs 0%).
CONCLUSION
The 2010 ARVC TFC do not reliably differentiate between CS patients fulfilling 2010 ARVC TFC and those with hereditary ARVC. Prolonged PR interval, advanced AVB, longer QRS duration, right ventricular apical involvement, reduced LVEF, and positive

Identifiants

pubmed: 32976989
pii: S1547-5271(20)30897-3
doi: 10.1016/j.hrthm.2020.09.015
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

231-238

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Alessio Gasperetti (A)

University Heart Center, University Hospital Zurich, Switzerland.

Valentina A Rossi (VA)

University Heart Center, University Hospital Zurich, Switzerland.

Alessandra Chiodini (A)

University Heart Center, University Hospital Zurich, Switzerland.

Michela Casella (M)

Cardiology and Arrhythmology Clinic, Department of Clinical, Special and Dental Sciences, University Hospital "Umberto I-Lancisi-Salesi," Marche Polytechnic University, Ancona, Italy.

Sarah Costa (S)

University Heart Center, University Hospital Zurich, Switzerland.

Deniz Akdis (D)

University Heart Center, University Hospital Zurich, Switzerland.

Ronny Büchel (R)

University Heart Center, University Hospital Zurich, Switzerland.

Antoine Deliniere (A)

Department of Heart and Vessels, Service of Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Etienne Pruvot (E)

Department of Heart and Vessels, Service of Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Christiane Gruner (C)

University Heart Center, University Hospital Zurich, Switzerland.

Corrado Carbucicchio (C)

Heart Rhythm Center, Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Robert Manka (R)

University Heart Center, University Hospital Zurich, Switzerland.

Antonio Dello Russo (A)

Cardiology and Arrhythmology Clinic, Department of Clinical, Special and Dental Sciences, University Hospital "Umberto I-Lancisi-Salesi," Marche Polytechnic University, Ancona, Italy.

Claudio Tondo (C)

Heart Rhythm Center, Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Corinna Brunckhorst (C)

University Heart Center, University Hospital Zurich, Switzerland.

Felix Tanner (F)

University Heart Center, University Hospital Zurich, Switzerland.

Firat Duru (F)

University Heart Center, University Hospital Zurich, Switzerland.

Ardan M Saguner (AM)

University Heart Center, University Hospital Zurich, Switzerland. Electronic address: ardansaguner@yahoo.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH